Search Result "cardiometabolic risk"


Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3690-3698
Author(s): I. Gouni-Berthold, H. K. Berthold

Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease

Journal: Current Hypertension Reviews
Volume: 7 Issue: 1 Year: 2011 Page: 29-40
Author(s): Taku Inoue, Yusuke Ohya

Cardiovascular Health vs Cardiovascular Risk A 2011 Update: Cardiovascular Risk Stratification, the Basis to Reach Therapeutic Goals

Journal: Current Hypertension Reviews
Volume: 7 Issue: 3 Year: 2011 Page: 126-136
Author(s): Enrique C. Morales Villegas

Liver Enzymes: Potential Cardiovascular Risk Markers?

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3632-3643
Author(s): Eirini Lioudaki, Emmanuel S. Ganotakis, Dimitri P. Mikhailidis

The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 908-921
Author(s): Frangiskos Economou, Xenofon Xyrafis, Charikleia Christakou, Evanthia Diamanti-Kandarakis

Vitamin D Insufficiency and Diabetes Risks

Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 61-87
Author(s): Barbara J. Boucher

Does in vitro Fertilisation Increase Type 2 Diabetes and Cardiovascular Risk?

Journal: Current Diabetes Reviews
Volume: 7 Issue: 6 Year: 2011 Page: 426-432
Author(s): Miaoxin Chen, Robert J. Norman, Leonie K. Heilbronn

Sympathetic Activation in Hypertension and in Hypertension-Related Metabolic Disease

Journal: Current Hypertension Reviews
Volume: 7 Issue: 2 Year: 2011 Page: 60-65
Author(s): Guido Grassi, Gianmaria Brambilla, Gino Seravalle

Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 6 Year: 2011 Page: 698-705
Author(s): Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis, Dimitri P. Mikhailidis

Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 4 Year: 2011 Page: 236-246
Author(s): Mohamed S. Ahmed, Jing Zhan Ji, Qing H. Meng

Previous   Next

Go To   Results 1 - 1 of 46

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy